ARCHIVES

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

House Encourages NCI To continue Leadership Role As Coordinator Of Cancer Program

October 8, 1999

FDA Encourages Randomized Trials For Medical Devices.

May 26, 2006

CCRAC Members Say Practicing Physicians Do Not Use Cancer Prevention Methods

August 24, 1979

NIH Programs: Mouse Is next In Line For DNA Sequencing

October 29, 1999

DCBD Concepts Approved

November 8, 1985

Ethics Commission to Meet In L.A.

September 4, 1981